232 related articles for article (PubMed ID: 27396340)
1. Post-translational Modifications of OLIG2 Regulate Glioma Invasion through the TGF-β Pathway.
Singh SK; Fiorelli R; Kupp R; Rajan S; Szeto E; Lo Cascio C; Maire CL; Sun Y; Alberta JA; Eschbacher JM; Ligon KL; Berens ME; Sanai N; Mehta S
Cell Rep; 2016 Jul; 16(4):950-966. PubMed ID: 27396340
[TBL] [Abstract][Full Text] [Related]
2. Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma.
Singh DK; Kollipara RK; Vemireddy V; Yang XL; Sun Y; Regmi N; Klingler S; Hatanpaa KJ; Raisanen J; Cho SK; Sirasanagandla S; Nannepaga S; Piccirillo S; Mashimo T; Wang S; Humphries CG; Mickey B; Maher EA; Zheng H; Kim RS; Kittler R; Bachoo RM
Cell Rep; 2017 Jan; 18(4):961-976. PubMed ID: 28122245
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA linc00645 promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-205-3p-ZEB1 axis in glioma.
Li C; Zheng H; Hou W; Bao H; Xiong J; Che W; Gu Y; Sun H; Liang P
Cell Death Dis; 2019 Sep; 10(10):717. PubMed ID: 31558707
[TBL] [Abstract][Full Text] [Related]
4. TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion.
Joseph JV; Conroy S; Tomar T; Eggens-Meijer E; Bhat K; Copray S; Walenkamp AM; Boddeke E; Balasubramanyian V; Wagemakers M; den Dunnen WF; Kruyt FA
Cell Death Dis; 2014 Oct; 5(10):e1443. PubMed ID: 25275602
[TBL] [Abstract][Full Text] [Related]
5. LINC01711 promotes transforming growth factor-beta (TGF-β) induced invasion in glioblastoma multiforme (GBM) by acting as a competing endogenous RNA for miR-34a and promoting ZEB1 expression.
Shree B; Sengar S; Tripathi S; Sharma V
Neurosci Lett; 2023 Jan; 792():136937. PubMed ID: 36341927
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1.
Jiang C; Shen F; Du J; Hu Z; Li X; Su J; Wang X; Huang X
Oncotarget; 2016 Aug; 7(35):56200-56208. PubMed ID: 27621042
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Epsin 3 enhances migration and invasion of glioma cells by inducing epithelial‑mesenchymal transition.
Wang Y; Song W; Kan P; Huang C; Ma Z; Wu Q; Yao X; Zhang B
Oncol Rep; 2018 Nov; 40(5):3049-3059. PubMed ID: 30226603
[TBL] [Abstract][Full Text] [Related]
8. Harnessing OLIG2 function in tumorigenicity and plasticity to target malignant gliomas.
Kosty J; Lu F; Kupp R; Mehta S; Lu QR
Cell Cycle; 2017 Sep; 16(18):1654-1660. PubMed ID: 28806136
[TBL] [Abstract][Full Text] [Related]
9. Repression of the expression of PPP3CC by ZEB1 confers activation of NF-κB and contributes to invasion and growth in glioma cells.
Wang H; Zhao S; Chen B; Fu C; Dang Y; Fang P; Wang J; Wang N; Liu L
Jpn J Clin Oncol; 2018 Feb; 48(2):175-183. PubMed ID: 29294030
[TBL] [Abstract][Full Text] [Related]
10. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.
Larsen JE; Nathan V; Osborne JK; Farrow RK; Deb D; Sullivan JP; Dospoy PD; Augustyn A; Hight SK; Sato M; Girard L; Behrens C; Wistuba II; Gazdar AF; Hayward NK; Minna JD
J Clin Invest; 2016 Sep; 126(9):3219-35. PubMed ID: 27500490
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
Cherry EM; Lee DW; Jung JU; Sitcheran R
Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
[TBL] [Abstract][Full Text] [Related]
12. Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling.
Hellinger JW; Schömel F; Buse JV; Lenz C; Bauerschmitz G; Emons G; Gründker C
Sci Rep; 2020 Oct; 10(1):17889. PubMed ID: 33087801
[TBL] [Abstract][Full Text] [Related]
13. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M
Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287
[TBL] [Abstract][Full Text] [Related]
14. TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells' invasion.
Zhang C; Zhang X; Xu R; Huang B; Chen AJ; Li C; Wang J; Li XG
J Exp Clin Cancer Res; 2017 Nov; 36(1):162. PubMed ID: 29145888
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
16. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
[TBL] [Abstract][Full Text] [Related]
17. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.
Wick W; Grimmel C; Wild-Bode C; Platten M; Arpin M; Weller M
J Neurosci; 2001 May; 21(10):3360-8. PubMed ID: 11331365
[TBL] [Abstract][Full Text] [Related]
18. Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion.
Rosmaninho P; Mükusch S; Piscopo V; Teixeira V; Raposo AA; Warta R; Bennewitz R; Tang Y; Herold-Mende C; Stifani S; Momma S; Castro DS
EMBO J; 2018 Aug; 37(15):. PubMed ID: 29903919
[TBL] [Abstract][Full Text] [Related]
19. Olig2 SUMOylation protects against genotoxic damage response by antagonizing p53 gene targeting.
Liu H; Weng W; Guo R; Zhou J; Xue J; Zhong S; Cheng J; Zhu MX; Pan SJ; Li Y
Cell Death Differ; 2020 Nov; 27(11):3146-3161. PubMed ID: 32483381
[TBL] [Abstract][Full Text] [Related]
20. Olig2 regulates p53-mediated apoptosis, migration and invasion of melanoma cells.
Lee JE; Ahn S; Jeong H; An S; Myung CH; Lee JA; Hong SC; Kim YJ; Kim JY; Ryu JH; Noh M; Nam KT; Hwang JS
Sci Rep; 2021 Apr; 11(1):7778. PubMed ID: 33833342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
